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I S1541 Broad-Spectlum PCR for the Detection of 
Uncultured Bacteria: Problems and Promises 
M. Altwegg. Department of Medical Microbiology, University of Zurich, 
Switzerland 
Amplification techniques have had an enormous impact on the dng- 
nosis of infections associated with bacteria that are difficult to culture 
on a routine basis for various reasons (previous antibiotic therapy, no 
suMv-A upon prolonged transport, requirement for cell cultures). In 
contrast to cultures, however, specific amplification assays can only 
be used if one or a few particular organisms need to be looked for. 
The concept of broad-spectrum PCR amp-g part of the 16s 
rFWA genes of all (most) bacteria by using primers directed against 
conserved regions of these molecules followed by direct sequenc- 
ing (i.e. without subcloning) of the amplified hgment or by using 
specific probes for identification provides a promising approach for 
the detection of any bacteria present in a particular chical material 
including as yet unknown organism. We have successfidy used this 
approach for detecting bacteria in culture-negative specimens (Eo- 
pheryma whippelii in a case of spondylodiscitis, BorreZia burgdorferi in 
s y n o d  specimens of patienu with reactive arthritis, T whippelii and 
other orgdnisms in heart valves of patients with endocarditis, etc.). 
This technique, however, is h t e d  to monobacterial infections and 
normally sterile specimens. In addition, it is usually less sensitive than 
species-specific assays because relatively large hgments need to be 
amplified to provide sufKcient sequence information for identifica- 
tion, and it is prone to reagent contamination (bacterial DNA in 
water, enzymes, etc.). 
m] Molecular Detection of Antibiotic Resistance 
M.R. Visser. NL 
No abstract available. 
Clinical Relevance of Quantitative PCR 
C. BrCchot. F 
No abstract available. 
The Clinician and Molecular Diagnostics: A 
Critical View 
ED. Goebel. D 
No abstract available. 
=/ The Cost-Effectiveness of Gene-Amplification 
Methods in Screening for Chlamydia 
trachomatis 
J.-M. Schulenburg, K. Obermann. Institute for Insurance Economicr, 
University of Hannover, Germany 
Objectives: Chlamydia trachomafic (CT) infection is characterised 
by a low clinical manifestation rate and subsequent chronic inflam- 
mation. Gene-amplification methods show a marked improvement 
in sensitivity to previously available kits but at a higher price. A 
cost-effectiveness analysis fivm the health insurance perspective was 
undertaken to assess the costs and benefits h m  using LCWPCR in 
comparison to other tests in screening women in Germany. 
Methods: A decision-tree was developed to assess the cost of an 
unrecognised CT-infection. We included all outcomes of infected 
female patients as well as those of their partner and newborn chil- 
dren. We used a Markov Chain model c h c a l  development of the 
unrecognised infection as well as the impact of screening. The tran- 
sition probabhties are based on literature review and expert inter- 
views. A detailed cost analysis for CT-related complications was un- 
dertaken and expert opinion was used to assess the cost for treating 
male patients and chddren. Average test kit sensitivities are based on 
a literature review, praalence data were taken h m  recent findings 
by Petersen et al., Freiburg. A sensitivity analysis was carried out 
regarding the test kit sensitivities, the transition probabilities and the 
Results: Any screening strategy employed with any test kit re- 
sulted in substantial cost savings compared to no screening. Using 
the more expensive but more sensitive LCFUPCR yielded additional 
savings between 20 and 207 million DM. The result are robust as 
shown by the sensitivity analysis. 
Conclusion: Screening for CT-infection in the female popula- 
tion is a cost-effective way to prevent chronic inflammation and 
subsequent sequelae due to this infection. LCFUF'CR-methods are 
most e6cient here. 
cost. 
Foreign body associated infections 
I s159 I Pathogenesis of device related infections 
FA. Waldvogel. Univmity Hospital, Geneva, Switzerland 
Implanted biomateriak are increasingly used in medxine, recon- 
structive surgery and chronic inland outpatient therapies. Dysfunc- 
tions, tissue intolerance and mfection are the 3 most dreaded compli- 
cations of indwelhg devices. Besides deficient antimicrobial mech- 
anisms such as neutrophil dysfunction, increased adherence to bio- 
materlak has been recognized as an important initiating step of in- 
fection: orthopedic, intravascular, and subcutaneous imphts  of var- 
ious chemical composition are rapidly coated by host proteins, in- 
cluding fibrinogen, fibronectin, thrombospondm. vitronectin. Fre- 
quently encountered pathogens such as S. nureus posses well char- 
acterized surface adhesions, such as clumping factor or fibronectin 
adhesion proteins, which interact specifically with known sequences 
on fibrinogen and fibronectin. Site specific mutations, complemen- 
tation experiments with doned genes, and lnhibition studies with 
truncated adhesions or antibodies confirm the importance of these 
factors in in vitro and in vim model. 
I S160 I Genetic and Biochemical Characterization of 
Staphylococcus epidennidis Biofilm 
Accumulation 
D. Mack. Insfihrte ofMed. Microbiology and Immunoloa, University 
Hospital Eppendod Hamburg, Germany 
The primary attachment to polymer surfaces followed by accumu- 
lation in multi-layered cell clusters leads to hiofilm-production of 
S. epidemidis, which is thought to contribute to virulence in for- 
eign-body infections. Using an absorbed antiserum raised against 
biofilm producing S. epidmidis 1457 an antigen specifically ex- 
pressed by biofilm producing S. epidennidis strains was detected. By 
transposon mutagenesis using Tn917 mutants of biofilm producing 
